Emtricitabine Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT02985996Body Compartment PK for New HIV Pre-exposure Prophylaxis Modalities
NCT00076791Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
NCT02904369PK and PD Study of Oral F/TAF for HIV Prevention
NCT01694407Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine